Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

Interim Results

27 Sep 2005 12:09

Azure Holdings Plc (" Company") Interim results for the six months ended 30 June 2005 Chairman's statementIn the six months ended 30 June 2005 the Company incurred a loss before andafter taxation of ‚£74,000 (2004: ‚£229,000).Because of the lack of cash in the Company, creditors have increased butcontinue to be supportive.The directors are continuing to keep overheads to a minimum, the expenses beingthose necessary to maintain the Company's listing on AIM.The board continues to seek an acquisition for the Company.Owing to a technicality, the Company no longer has any authority to issue anyof its share capital and will therefore be convening an extraordinary generalmeeting for this purpose.Nicolas GreenstoneChairman27 September 2005Azure Holdings plcProfit and Loss Accountfor the six months ended 30 June 2005 6 months 6 months Year ended ended 30 ended 30 31 December June 2004 2004 June 2005 (unaudited) (audited) (unaudited) ‚£'000 ‚£'000 ‚£'000 Turnover - - - Administrative expenses (74) (229) (345) Operating loss (74) (229) (345) Loss on ordinary activities before (74) (229) (345)taxation Tax on loss on ordinary activities - - - Loss on ordinary activities after (74) (229) (345)taxation Retained loss for the period (74) (229) (345) Loss per ordinary share (0.15p) (0.65p) (0.86p) The profit and loss account has been prepared on the basis that all operationsare continuing operations. All recognised gains or losses are dealt withthrough the profit and loss account or statement of recognised gains andlosses.Azure Holdings plcBalance Sheetas at 30 June 2005 30 June 2005 30 June 31 December 2004 2004 (unaudited) (unaudited) (audited) ‚£'000 ‚£'000 ‚£'000 Current assets Debtors 3 14 7 Cash at bank and in hand 1 10 14 4 24 21 Creditors: amounts falling due within one (147) (81) (90)year Net current liabilities (143) (57) (69) Total assets less current liabilities (143) (57) (69) Net liabilities (143) (57) (69) Capital and reserves Called up Share Capital 5,475 5,371 5,475 Share Premium 10,279 10,279 10,279 Profit and loss account (15,897) (15,707) (15,823) Equity shareholders deficit (143) (57) (69) Azure Holdings plcCash Flow Statementfor the six months ended 30 June 2005 6 months ended 6 months ended 30 June 2005 30 June 2004 (unaudited) (unaudited) ‚£'000 ‚£'000 Net cash outflow from operating (13) (214)activities Financing Issue of ordinary shares - 105 Decrease in cash (13) (109)Azure Holdings plcNotes to the Interim Results 1. The interim results are unaudited and do not constitute statutory accounts within the meaning of section 240 of the Companies Act 1985. The figures for the year ended 31 December 2004 have been extracted from the statutory accounts filed with the registrar of companies on which the auditors gave an unqualified report. 2. The interim results have been prepared using the accounting policies set out in the statutory accounts for the year ended 31 December 2004. 3. The comparative figures for the unaudited interim results for the period ended 30 June 2004 are stated as announced on 29 September 2004. 4. Loss per share The earnings per share for the six months ended 30 June 2005 has beencalculated on the basis of the loss after taxation for the period of ‚£74,000(2004: ‚£229,000 ) and the weighted average number of shares in issue during theperiod of 48,317,569 (2004: 35,417,565). 5. The directors do not propose to pay a dividend for the period. 6. Copies of the interim results are available from the Company's registered office, One Great Cumberland Place, London, W1H 7AL. ENDAZURE HOLDINGS PLC
Date   Source Headline
12th Dec 20078:31 amPRNPhysiomics Collaboration Update
11th Dec 20077:00 amPRNValiBIO Update
27th Nov 20079:27 amPRNIssue of Equity
12th Nov 20077:00 amPRNEuropean Technology Patent for Nucleosomics
25th Oct 20074:00 pmPRNDirectorate Change
15th Oct 20077:00 amPRNLicense Agreement
28th Sep 200710:00 amPRNInterim Report
28th Sep 20077:01 amRNSTotal Voting Rights
26th Sep 20073:31 pmRNSIssue of Equity
21st Sep 20074:09 pmRNSPlacing
10th Sep 20077:00 amPRNGeneICE CRT update
17th Aug 20076:07 pmRNSAIM Rule 26 Information
8th Aug 20077:00 amPRNEuropean GeneICE Patent Granted and CRT Trials Update
31st Jul 20074:10 pmRNSTotal Voting Rights
27th Jul 200710:27 amRNSResult of AGM
19th Jul 20077:00 amPRNJoint Venture
18th Jul 20072:16 pmRNSIssue of Equity
25th Jun 20072:00 pmPRNFinal Results
12th Jun 200712:00 pmPRNValiRx partners with Clarity Imaging
14th May 20077:00 amPRNCRT / Cronos agreement extension
26th Apr 20077:00 amPRNUS GeneICE Patent Granted
18th Apr 20077:00 amPRNResearch & Development Update
4th Apr 20077:00 amPRNUniversity of Surrey - Collaborative Agreement
27th Mar 20073:45 pmRNSChange of address
15th Feb 20077:00 amPRNPhysiomics plc - Agreement
9th Jan 200712:10 pmPRNAppointment of Non-Executive Director
22nd Dec 200611:40 amRNSTotal Voting Rights
11th Dec 20067:00 amRNSIntended Grant of Patent
4th Dec 20067:00 amRNSMorphogenesis Inc
3rd Oct 20067:00 amRNSAdditional Listing
2nd Oct 20062:33 pmRNSResult of EGM
29th Sep 20061:03 pmRNSConfirmation of Share Capital
26th Sep 20064:46 pmRNSInterim Results
18th Sep 20064:36 pmRNSSchedule 1 - Azure Holdings
11th Sep 20067:00 amRNSRestoration - Azure Holdings
11th Sep 20067:00 amRNSPropsd Aqstn & Notice of EGM
4th Aug 200611:06 amRNSConvertible Loan Note Offer
18th Jul 20063:48 pmRNSConvertible Loan Note Offer
29th Jun 200612:20 pmRNSFinal Results
8th Jun 20068:25 amRNSChange of registered office
12th May 20062:54 pmRNSChange of Adviser
12th May 20062:49 pmRNSDirectorate Change
3rd Apr 20069:44 amPRNStatement re Suspension
3rd Apr 20067:01 amRNSSuspension - Azure Holdings
22nd Mar 20066:15 pmPRNChange of Registered Office
22nd Mar 20066:15 pmPRNChange of Registered Office
10th Mar 20063:45 pmPRNResult of EGM
11th Jan 20061:09 pmPRNResult of EGM
27th Sep 200512:09 pmPRNInterim Results
23rd Jun 20052:42 pmPRNFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.